Lv5
1340 积分 2023-10-12 加入
Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram
2天前
已完结
Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes
2天前
已完结
Predictors of Distant Metastases in Triple-Negative Breast Cancer Without Pathologic Complete Response After Neoadjuvant Chemotherapy
5天前
已完结
Initial MRI findings predictive of a pathological complete response to neoadjuvant treatments in HER2-positive breast cancers
6天前
已完结
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
1个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
1个月前
已完结
皖公网安备34019202002308
